Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Phillip M. Devlin, M.D.

TitleAssociate Professor of Radiation Oncology
InstitutionBrigham and Women's Hospital
DepartmentRadiation Oncology
AddressBrigham and Women's Hospital
Radiation Oncology, L2
75 Francis St
Boston MA 02115
Phone617/732-6310
Fax617/278-6988
vCardDownload vCard (login for email)

 Mentoring 
 completed student projects
Comparison of two dose-fractionation schemes in toxicity, efficacy, and cosmesis for early stage, low risk breast cancer patients undergoing MammoSite accelerated partial breast irradiation
Summer, 06/16/08 - 12/19/08
Family Hisotry, TP53, and MDM2 in Childhood Cancer Survivors
Summer, 06/18/07 - 08/10/07

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Abou Al-Shaar H, Almefty KK, Abolfotoh M, Arvold ND, Devlin PM, Reardon DA, Loeffler JS, Al-Mefty O. Brachytherapy in the treatment of recurrent aggressive falcine meningiomas. J Neurooncol. 2015 Sep; 124(3):515-22.
    View in: PubMed
  2. Wagar M, Bhagwat M, O'Farrell D, Friesen S, Buzurovic I, Damato A, Devlin P, Cormack R. SU-E-T-413: Examining Acquisition Rate for Using MatriXX Ion Chamber Array to Measure HDR Brachytherapy Treatments. Med Phys. 2015 Jun; 42(6):3429.
    View in: PubMed
  3. Buzurovic I, Hansen J, Bhagwat M, O'Farrell D, Damato A, Friesen S, Devlin P, Cormack R. SU-E-T-165: Characterization of Dose Distributions in High-Dose-Rate Surface Brachytherapy. Med Phys. 2015 Jun; 42(6):3369.
    View in: PubMed
  4. Sugar EN, Buzurovic I, O'Farrell D, Hansen J, Devlin P, Cormack R, Nguyen P. SU-E-T-301: Dosimetric Comparison Between Adaptive and Rectilinear Template-Based Prostate Seed Implants. Med Phys. 2015 Jun; 42(6):3402.
    View in: PubMed
  5. Bhagwat M, O'Farrell D, Wagar M, Buzurovic I, Friesen S, Damato A, Devlin P, Cormack R. SU-E-T-783: Using Matrixx to Determine Transit Dose Contribution Over Clinically Useful Limits of HDR Source Activity. Med Phys. 2015 Jun; 42(6):3517.
    View in: PubMed
  6. Muralidhar V, Mahal BA, Ziehr DR, Chen YW, Nezolosky MD, Viswanathan VB, Beard CJ, Devlin PM, Martin NE, Orio PF, Nguyen PL. Shifting brachytherapy monotherapy case mix toward intermediate-risk prostate cancer. Brachytherapy. 2015 Jul-Aug; 14(4):511-6.
    View in: PubMed
  7. Lane JD, Pomahac B, Raut CP, Baldini EH, Devlin PM. High-dose-rate Interstitial Brachytherapy Boost with a Pedicled Latissimus Dorsi Myocutaneous Flap for Myxofibrosarcoma of the Arm. Plast Reconstr Surg Glob Open. 2014 Oct; 2(10):e229.
    View in: PubMed
  8. Fairweather M, Wang J, Devlin PM, Hansen J, Baldini EH, Ready JE, Sugarbaker DJ, Bertagnolli MM, Raut CP. Safety and Efficacy of Radiation Dose Delivered via Iodine-125 Brachytherapy Mesh Implantation for Deep Cavity Sarcomas. Ann Surg Oncol. 2015 May; 22(5):1455-63.
    View in: PubMed
  9. Damato AL, Devlin PM, Bhagwat MS, Buzurovic I, Friesen S, Hansen JL, Lee LJ, Molodowitch C, Nguyen PL, O'Farrell DA, Viswanathan AN, Williams CL, Killoran JH, Cormack RA. Independent brachytherapy plan verification software: Improving efficacy and efficiency. Radiother Oncol. 2014 Dec; 113(3):420-4.
    View in: PubMed
  10. Murciano-Goroff YR, Wolfsberger LD, Parekh A, Fennessy FM, Tuncali K, Orio PF, Niedermayr TR, Suh WW, Devlin PM, Tempany CM, Sugar EH, O'Farrell DA, Steele G, O'Leary M, Buzurovic I, Damato AL, Cormack RA, Fedorov AY, Nguyen PL. Variability in MRI vs. ultrasound measures of prostate volume and its impact on treatment recommendations for favorable-risk prostate cancer patients: a case series. Radiat Oncol. 2014; 9:200.
    View in: PubMed
  11. Mahal BA, Ziehr DR, Hyatt AS, Neubauer-Sugar EH, O'Farrell DA, O'Leary MP, Steele GS, Niedermayr TR, Beard CJ, Martin NE, Orio PF, D'Amico AV, Devlin PM, Nguyen PL. Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results. Brachytherapy. 2014 Sep-Oct; 13(5):442-9.
    View in: PubMed
  12. Nguyen PL, Hyatt AS, Devlin PM. PSA screening: the case in favor. Oncology (Williston Park). 2013 Oct; 27(10):980, 982.
    View in: PubMed
  13. Stewart AJ, Hepel JT, O'Farrell DA, Devlin PM, Price LL, Dale RG, Wazer DE. Equivalent uniform dose for accelerated partial breast irradiation using the MammoSite applicator. Radiother Oncol. 2013 Aug; 108(2):232-5.
    View in: PubMed
  14. Garibyan L, Cotter SE, Hansen JL, Noell C, Dorosario A, O'Farrell DA, Devlin PM, Wang LC. Palliative treatment for in-transit cutaneous metastases of Merkel cell carcinoma using surface-mold computer-optimized high-dose-rate brachytherapy. Cancer J. 2013 Jul-Aug; 19(4):283-7.
    View in: PubMed
  15. DeSimone JA, Guenova E, Carter JB, Chaney KS, Aldridge JR, Noell CM, Dorosario AA, Hansen JL, Kupper TS, Devlin PM. Low-dose high-dose-rate brachytherapy in the treatment of facial lesions of cutaneous T-cell lymphoma. J Am Acad Dermatol. 2013 Jul; 69(1):61-5.
    View in: PubMed
  16. Holloway CL, Delaney TF, Alektiar KM, Devlin PM, O'Farrell DA, Demanes DJ. American Brachytherapy Society (ABS) consensus statement for sarcoma brachytherapy. Brachytherapy. 2013 May-Jun; 12(3):179-90.
    View in: PubMed
  17. McBride SM, Raut CP, Lapidus M, Devlin PM, Marcus KJ, Bertagnolli M, George S, Baldini EH. Locoregional recurrence after preoperative radiation therapy for retroperitoneal sarcoma: adverse impact of multifocal disease and potential implications of dose escalation. Ann Surg Oncol. 2013 Jul; 20(7):2140-7.
    View in: PubMed
  18. Baldini EH, Lapidus MR, Wang Q, Manola J, Orgill DP, Pomahac B, Marcus KJ, Bertagnolli MM, Devlin PM, George S, Abraham J, Ferrone ML, Ready JE, Raut CP. Predictors for major wound complications following preoperative radiotherapy and surgery for soft-tissue sarcoma of the extremities and trunk: importance of tumor proximity to skin surface. Ann Surg Oncol. 2013 May; 20(5):1494-9.
    View in: PubMed
  19. Goodman KA, Khalid N, Kachnic LA, Minsky BD, Crozier C, Owen JB, Devlin PM, Thomas CR. Quality Research in Radiation Oncology analysis of clinical performance measures in the management of gastric cancer. Int J Radiat Oncol Biol Phys. 2013 Feb 1; 85(2):355-62.
    View in: PubMed
  20. Zelefsky MJ, Cohen GN, Bosch WR, Morikawa L, Khalid N, Crozier CL, Lee WR, Zietman A, Owen J, Wilson JF, Devlin PM. Results from the Quality Research in Radiation Oncology (QRRO) survey: Evaluation of dosimetric outcomes for low-dose-rate prostate brachytherapy. Brachytherapy. 2013 Jan-Feb; 12(1):19-24.
    View in: PubMed
  21. Nguyen PL, Devlin PM, Beard CJ, Orio PF, O'Leary MP, Wolfsberger LD, O'Farrell DA, Sweeney CM, Hadaschik BA, Hohenfellner M, Hatiboglu G. High-dose-rate brachytherapy for prostate cancer in a previously radiated patient with polyethylene glycol hydrogel spacing to reduce rectal dose: case report and review of the literature. Brachytherapy. 2013 Jan-Feb; 12(1):77-83.
    View in: PubMed
  22. Cotter SE, Dunn GP, Collins KM, Sahni D, Zukotynski KA, Hansen JL, O'Farrell DA, Ng AK, Devlin PM, Wang LC. Abscopal effect in a patient with metastatic Merkel cell carcinoma following radiation therapy: potential role of induced antitumor immunity. Arch Dermatol. 2011 Jul; 147(7):870-2.
    View in: PubMed
  23. Sher DJ, Posner MR, Tishler RB, Sarlis NJ, Haddad RI, Holupka EJ, Devlin PM. Relationship between radiation treatment time and overall survival after induction chemotherapy for locally advanced head-and-neck carcinoma: a subset analysis of TAX 324. Int J Radiat Oncol Biol Phys. 2011 Dec 1; 81(5):e813-8.
    View in: PubMed
  24. Cotter SE, Devlin PM, Sahni D, Hansen JL, O'Farrell DA, Ng AK, Wang LC. Treatment of cutaneous metastases of Merkel cell carcinoma with surface-mold computer-optimized high-dose-rate brachytherapy. J Clin Oncol. 2010 Sep 20; 28(27):e464-6.
    View in: PubMed
  25. Ahmed HM, Dipiro PJ, Devlin PM, Nguyen ML, Bellon JR. Mammographic appearance following accelerated partial breast irradiation by using MammoSite brachytherapy. Radiology. 2010 May; 255(2):362-8.
    View in: PubMed
  26. Stewart AJ, Khan AJ, Devlin PM. Partial breast irradiation: a review of techniques and indications. Br J Radiol. 2010 May; 83(989):369-78.
    View in: PubMed
  27. Stewart AJ, Devlin PM, Mutyala S. Counterpoint: the dose rate argument--Does size matter after all? Brachytherapy. 2009 Jul-Sep; 8(3):273-5.
    View in: PubMed
  28. Mutyala S, Devlin PM, Stewart AJ. Rebuttal to Drs. Davidson, Hendry, and West: once burned, twice shy? Brachytherapy. 2009 Jul-Sep; 8(3):277.
    View in: PubMed
  29. Mutyala S, Stewart A, Khan AJ, Cormack RA, O'Farrell D, Sugarbaker D, Devlin PM. Permanent iodine-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies. Int J Radiat Oncol Biol Phys. 2010 Mar 15; 76(4):1114-20.
    View in: PubMed
  30. Siddiqi NH, Devlin PM. Radiation lobectomy-a minimally invasive treatment model for liver cancer: case report. J Vasc Interv Radiol. 2009 May; 20(5):664-9.
    View in: PubMed
  31. Stewart AJ, Mutyala S, Holloway CL, Colson YL, Devlin PM. Intraoperative seed placement for thoracic malignancy-A review of technique, indications, and published literature. Brachytherapy. 2009 Jan-Mar; 8(1):63-9.
    View in: PubMed
  32. Stewart AJ, O'Farrell DA, Cormack RA, Hansen JL, Khan AJ, Mutyala S, Devlin PM. Dose volume histogram analysis of normal structures associated with accelerated partial breast irradiation delivered by high dose rate brachytherapy and comparison with whole breast external beam radiotherapy fields. Radiat Oncol. 2008; 3:39.
    View in: PubMed
  33. Tripuraneni P, Watson RL, Ang KK, Harrison L, Eifel P, Zietman A, Haffty B, Thevenot LI, Willett CG, Schomberg PJ, Pickles T, Halberg FE, Devlin PM. Intersociety Radiation Oncology Summit-SCOPE II. Int J Radiat Oncol Biol Phys. 2008 Oct 1; 72(2):323-6.
    View in: PubMed
  34. Siddiqi NH, Khan AJ, Devlin PM. Palonosetron--a single-dose antiemetic adjunct for hepatic artery radioembolization: a feasibility study. Cardiovasc Intervent Radiol. 2009 Jan; 32(1):47-51.
    View in: PubMed
  35. Cormack RA, Devlin PM. Brachytherapy partial breast irradiation: analyzing effect of source configurations on dose metrics relevant to toxicity. Int J Radiat Oncol Biol Phys. 2008 Jul 1; 71(3):940-4.
    View in: PubMed
  36. Iosifescu DV, Greenwald S, Devlin P, Perlis RH, Denninger JW, Alpert JE, Fava M. Pretreatment frontal EEG and changes in suicidal ideation during SSRI treatment in major depressive disorder. Acta Psychiatr Scand. 2008 Apr; 117(4):271-6.
    View in: PubMed
  37. Cormack RA, Holloway CL, O'Farrell D, Devlin PM. Permanent planar iodine-125 implants: the dosimetric effect of geometric parameters for idealized source configurations. Int J Radiat Oncol Biol Phys. 2007 Nov 15; 69(4):1310-5.
    View in: PubMed
  38. Albert M, Song JS, Schultz D, Cormack RA, Tempany CM, Haker S, Devlin PM, Beard C, Hurwitz MD, Suh WW, Jolesz F, D'Amico AV. Defining the rectal dose constraint for permanent radioactive seed implantation of the prostate. Urol Oncol. 2008 Mar-Apr; 26(2):147-52.
    View in: PubMed
  39. Mutyala S, Choi W, Khan AJ, Yaparpalvi R, Stewart AJ, Devlin PM. Inherent change in MammoSite applicator three-dimensional geometry over time. Radiat Oncol. 2007; 2:37.
    View in: PubMed
  40. Rivard MJ, Butler WM, Devlin PM, Hayes JK, Hearn RA, Lief EP, Meigooni AS, Merrick GS, Williamson JF. American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103. Brachytherapy. 2007 Jan-Mar; 6(1):34-7.
    View in: PubMed
  41. Stewart AJ, O'Farrell DA, Mutyala S, Bueno R, Sugarbaker DJ, Cormack RA, Devlin PM. Severe toxicity after permanent radioactive seed implantation for mediastinal carcinoid tumors. Brachytherapy. 2007 Jan-Mar; 6(1):58-61.
    View in: PubMed
  42. Viswanathan AN, Cormack R, Holloway CL, Tanaka C, O'Farrell D, Devlin PM, Tempany C. Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer. Int J Radiat Oncol Biol Phys. 2006 Sep 1; 66(1):91-9.
    View in: PubMed
  43. Stewart AJ, Devlin PM. The history of the smallpox vaccine. J Infect. 2006 May; 52(5):329-34.
    View in: PubMed
  44. Mager DL, Haffajee AD, Devlin PM, Norris CM, Posner MR, Goodson JM. The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med. 2005; 3:27.
    View in: PubMed
  45. Karakoyun-Celik O, Norris CM, Tishler R, Mahadevan A, Clark JR, Goldberg S, Devlin P, Busse PM. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base. Head Neck. 2005 May; 27(5):353-61.
    View in: PubMed
  46. Stewart AJ, O'Farrell DA, Bellon JR, Hansen JL, Duggan C, Czerminska MA, Cormack RA, Devlin PM. CT computer-optimized high-dose-rate brachytherapy with surface applicator technique for scar boost radiation after breast reconstruction surgery. Brachytherapy. 2005; 4(3):224-9.
    View in: PubMed
  47. Devlin PM, Kazakin J, Adak S, Li Y, Norris CM, Tishler RB, Clark JR, Busse PM, Posner MR. Prospective phase II trial of PFL-induction chemotherapy followed by definitive local treatment for advanced squamous cell carcinoma of the head and neck: 10-year follow-up. Am J Clin Oncol. 2004 Aug; 27(4):369-75.
    View in: PubMed
  48. Iftimia I, Devlin PM, Martin AG, Shakur R, Almonacid A, Kazakin J, Chin LM, Cormack RA. Dosimetric consequences of manual pullback procedure for coronary artery radiotherapy with 90Sr/90Y beta-source. Brachytherapy. 2004; 3(4):215-21.
    View in: PubMed
  49. Iftimia I, Devlin PM, Chin LM, Baron JM, Cormack RA. GAF film dosimetry of a tandem positioned beta-emitting intravascular brachytherapy source train. Med Phys. 2003 Jun; 30(6):1004-12.
    View in: PubMed
  50. Jeter MD, Jänne PA, Brooks S, Burstein HJ, Wen P, Fuchs CS, Loeffler JS, Devlin PM, Salgia R. Gemcitabine-induced radiation recall. Int J Radiat Oncol Biol Phys. 2002 Jun 1; 53(2):394-400.
    View in: PubMed
  51. Devlin PM, Brus CR, Kazakin J, Mitchell RB, Demanes DJ, Edmundson G, Gribble M, Gustafson GS, Kelly DA, Linares LA, Martinez AA, Mate TP, Nag S, Perez CA, Rao JG, Rodriguez RR, Shasha D, Tripuraneni P. An Internet-ready database for prospective randomized clinical trials of high-dose-rate brachytherapy for adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys. 2002 May 1; 53(1):104-15.
    View in: PubMed
  52. Devlin PM, Harrison LB. Brachytherapy for soft tissue sarcomas. Cancer Treat Res. 1997; 91:107-28.
    View in: PubMed
  53. Hata S, Clabby M, Devlin P, Spits H, De Vries JE, Krangel MS. Diversity and organization of human T cell receptor delta variable gene segments. J Exp Med. 1989 Jan 1; 169(1):41-57.
    View in: PubMed
  54. Hata S, Satyanarayana K, Devlin P, Band H, McLean J, Strominger JL, Brenner MB, Krangel MS. Extensive junctional diversity of rearranged human T cell receptor delta genes. Science. 1988 Jun 10; 240(4858):1541-4.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For demographic and contact information changes only, HMS/HSDM faculty should contact Human Resources at human_resourceshms.harvard.edu.
Devlin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_